Partex NV

Partex NV is the first digital pharma platform that is set to be the largest AI-powered Drug Assets Manager.

[Partex NV @PartexNV]

🚨 Big news! @PartexNV partners with @fortressbio (#NASDAQ: $FBIO) to accelerate asset identification using our proprietary AI platform. Together, we're reshaping drug discovery with cutting-edge tech + clinical expertise.
Link: https://t.co/JfEGtRPBNs

#AI #BIOTECH #NEWS

[Partex NV @PartexNV]

Exciting news!
Partex expands its collab with Ark Biosciences to out-license AK0658, a next-gen ATR inhibitor with best-in-class promise. Powered by our AI platform Asset42, we’re unlocking new cancer indications globally.
🔗 https://t.co/7aor10OYfA

[Partex NV @PartexNV]

🚀 @Innoplexus, in collaboration with @FraunhoferITMP, Goethe University, & University of Latvia, has won the @Roche & @genentech MS #Innovation Challenge Grant!

Our #AI-driven project (@Ontosight_ai) aims to improve early detection and personalized care for #MS patients using

[Partex NV @PartexNV]

Excited to be at #NVIDIAGTC25 in San Jose showcasing Partex’s AI-powered drug discovery platform as part of the @nvidia Inception program! 💊🤖

We're accelerating drug discovery—saving time, saving billions, saving lives. 🙌

Come say hi! 👋
#AI #HealthTech #DrugDiscovery

[Fortress Biotech @fortressbio]

Partex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform $FBIO https://t.co/ydIQtlrZSK

[Partex NV @PartexNV]

🚀 Partex is heading to @nvidia #GTC25 — NVIDIA’s flagship AI conference!

Let’s connect in San Jose, March 17–21, 2025, and explore how we’re transforming healthcare with AI & data.

🤝 Meet us there!

#Partex #AI #PrecisionMedicine #HealthTech #NVIDIA #GTC2025

[Partex NV @PartexNV]

🌸 Celebrating Women Every Day | #IWD2025

Although International Women's Day has passed, we continue to appreciate and admire the incredible women at @PartexNV everyday.

Also see some moments captured from our celebration: https://t.co/CkjDo0ymH8

Let’s continue to uplift!

[Partex NV @PartexNV]

@NVIDIAGTC 2025 (March 17-21, San Jose, CA)

Join us at Booth 3102 for groundbreaking AI in #biotech & #drugdiscovery:

🔬 200M #Protein-Protein Interactions analysed in seconds with NVIDIA BioNeMo, OpenFold & EquiDock

💡 3D BiCycle GANs + #LLMs for next-gen ligand design

[Partex NV @PartexNV]

Convergence of RWD and AI.

Read now: https://t.co/tAyV8qv5vh

#RWD #AI #Tech #Trending #viral #technology #Partex

[Partex NV @PartexNV]

Glad to see our CEO @Gunjan_GB on this esteemed panel, contributing to this crucial conversation about Data Sovereignty at #AIActionSummit2025 #LeadershipInAI

[Ministry of Electronics & IT @GoI_MeitY]

Shri @abhish18, Additional Secretary @GoI_MeitY,
@shashidigital (Co-Founder, @AI4IndiaOrg), @Gunjan_GB (Co-Founder and CEO @PartexNV), and @ChetanAggarwal (Visiting Fellow, @CPRGIndia) explored how data governance's legal, and strategic dimensions can play a critical role.

[Partex NV @PartexNV]

Adverse Drug Reactions are a substantial source of morbidity and mortality worldwide and can result in hospitalization, prolongation of hospital stays, and increased healthcare costs. Identifying and reporting adverse reactions in newly tested drugs can be challenging.

#Partex

[Partex NV @PartexNV]

AI is transforming drug discovery by delivering impressive returns on investment. Techniques like protein structure modelling, disease representation models, and advanced biological methods are empowering researchers.
Reach out to us to know more, [email protected]

#AI #Partex

[Partex NV @PartexNV]

Reducing 86% of Clinical Trials that Fail, with AI.

Time to adopt better strategies for better efficiency in drug development

Read Now: https://t.co/njQ4PQfYNy

#AI #Tech #ClinicalTrials #Viral #Trending #Drug #Partex

[Partex NV @PartexNV]

90% of biopharma and medtech leaders are embracing its game-changing impact of GenAI. In fact, 66% leverage its abilities for business operations.

Partner with us to harness the power of AI for drug development. Reach out to [email protected]

#AI #technology #Partex #Healthcare

[Partex NV @PartexNV]

Our CEO, @Gunjan_GB , joins the @TechTourHQ AI for Health, an exclusive event on the panel: "AI in Healthcare – Where will it have the most impact?"

📅 23 Jan 2025 | 09:10 CET | Bochum, Germany

#Event: https://t.co/rOeyKQYyqw

#AI #Health #Investor

[Partex NV @PartexNV]

🚀 Unlock smarter research with https://t.co/m3uFBVnzdl! Powered by AI, we bring you deep insights, faster analytics, and access to 36M+ publications and 600K+ clinical trials.

Start discovering smarter today!
#AI #MedicalResearch #AIAgent #HealthcareInnovation #ResearchTools

[Partex NV @PartexNV]

New Publication Alert!

"Amino Acids Frequency and Interaction Trends: Comprehensive Analysis of Viral Antigen-Antibody Complexes" Explore how amino acid composition shapes therapeutic antibody interactions against viral antigens.

🔗 https://t.co/SIPIYoiVFm

@SpringerNature

[Partex NV @PartexNV]

Partex is attending the @jpmorgan Healthcare Conference!
Connect with our leadership: Dr. @Gunjan_GB Bhardwaj, Dr. Frank Grams, Sven Krause,

Reach out at [email protected] to secure a meeting.
Let’s shape the future of healthcare together!

#JPMSanFrancisco #Partex #Conference

[Partex NV @PartexNV]

Excited to announce that Dr. Frank Grams, CCO @PartexNV, has been invited to present at the Deep Dive – Generative AI in Life Sciences event by @BioAlps !

He’ll share insights on how #GenAI is transforming life sciences!

#events #healthcare #AI #Pharma @BiopoleLausanne

[Partex NV @PartexNV]

@PartexNV announces strategic collaboration with Shanghai Ark Biopharmaceutical for Partnership and Out-Licensing of AK0707

Read full PR: https://t.co/FLjYNbRMiH

#AI #PharmaNews #DrugAssets